Loading company…
Ruishixingchen Biotechnology develops cell-based technologies for healthcare applications.
Founded in 2024 and based in Hangzhou, China, Ruishixingchen Biotechnology develops cell-based technologies for disease treatment and health management. It provides technical support to the healthcare sector and is advancing an iPSC differentiated corneal endothelial cell therapy pipeline. In November 2025, it raised Angel funding led by Huafang Capital, with participation from Hangzhou High-Tech Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in